AMEDISYS INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2010 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Amedisys Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q1 2024.
- Amedisys Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $2.59M, a 6.42% decline year-over-year.
- Amedisys Inc annual Deferred Income Tax Expense (Benefit) for 2023 was $20.7M, a 11.6% decline from 2022.
- Amedisys Inc annual Deferred Income Tax Expense (Benefit) for 2022 was $23.4M, a 47.6% decline from 2021.
- Amedisys Inc annual Deferred Income Tax Expense (Benefit) for 2021 was $44.6M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)